Literature DB >> 12794264

Immunopathogenesis of Sjögren's syndrome.

Andrea T Borchers1, Stanley M Naguwa, Carl L Keen, M Eric Gershwin.   

Abstract

Sjögren's syndrome (SS) is an autoimmune disease characterized by the sicca symptoms of dry eyes and dry mouth. Glandular dysfunction is thought to arise from destruction associated with lymphocytic infiltration. The degree of glandular destruction, however, does not correlate with the severity of sicca symptoms, suggesting that other mechanisms are involved, including abnormalities in parasympathetic neurotransmission. Autoantibodies against the muscarinic acetylcholine receptor have been implicated in this process, but multiple other autoantibodies have been found. Cytokines elaborated in the inflammatory lesions also appear to be involved and dysregulation of apoptosis are also involved in the pathogenesis of SS. A new two-stage model of SS has been proposed. First, there is a lymphocyte-independent phase during which inappropriate apoptosis results in the generation of apoptotic autoantigens which then attract lymphocytes. Subsequently, in the second lymphocyte-dependent phase, an immune attack causes further cell death and salivary dysfunction. Although the disease generally takes a rather stable and benign course, patients with SS have a significant risk of developing B cell lymphoma.

Entities:  

Mesh:

Year:  2003        PMID: 12794264     DOI: 10.1385/CRIAI:25:1:89

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  113 in total

1.  Specific amino acid residues in the second hypervariable region of HLA-DQA1 and DQB1 chain genes promote the Ro (SS-A)/La (SS-B) autoantibody responses.

Authors:  J D Reveille; M J Macleod; K Whittington; F C Arnett
Journal:  J Immunol       Date:  1991-06-01       Impact factor: 5.422

2.  Polymorphisms of HLA class II genes and autoimmune responses to Ro/SS-A-La/SS-B among Japanese subjects.

Authors:  S Miyagawa; K Shinohara; M Nakajima; K Kidoguchi; T Fujita; T Fukumoto; A Yoshioka; K Dohi; T Shirai
Journal:  Arthritis Rheum       Date:  1998-05

3.  Accessibility of SSA/Ro and SSB/La antigens to maternal autoantibodies in apoptotic human fetal cardiac myocytes.

Authors:  M E Miranda; C E Tseng; W Rashbaum; R L Ochs; C A Casiano; F Di Donato; E K Chan; J P Buyon
Journal:  J Immunol       Date:  1998-11-01       Impact factor: 5.422

4.  Analysis of the T-cell receptor Valpha repertoire and cytokine gene expression in Sjögren's syndrome.

Authors:  R A Ajjan; R S McIntosh; E A Waterman; P F Watson; C D Franklin; C M Yeoman; A P Weetman
Journal:  Br J Rheumatol       Date:  1998-02

5.  Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community.

Authors:  C Vitali; S Bombardieri; H M Moutsopoulos; G Balestrieri; W Bencivelli; R M Bernstein; K B Bjerrum; S Braga; J Coll; S de Vita
Journal:  Arthritis Rheum       Date:  1993-03

Review 6.  Role of apoptosis in autoimmunity.

Authors:  H M Lorenz; M Herrmann; T Winkler; U Gaipl; J R Kalden
Journal:  Apoptosis       Date:  2000-11       Impact factor: 4.677

7.  Primary Sjögren's syndrome in the North East of England: a long-term follow-up study.

Authors:  B K Davidson; C A Kelly; I D Griffiths
Journal:  Rheumatology (Oxford)       Date:  1999-03       Impact factor: 7.580

8.  DRB1*15 and DRB1*03 extended haplotype interaction in primary Sjögren's syndrome genetic susceptibility.

Authors:  S Jean; E Quelvennec; M Alizadeh; P Guggenbuhl; B Birebent; A Perdriger; B Grosbois; P Y Pawlotsky; G Semana
Journal:  Clin Exp Rheumatol       Date:  1998 Nov-Dec       Impact factor: 4.473

9.  Role of salivary IgA in the pathogenesis of Sjögren syndrome.

Authors:  Alejandro Berra; Leonor Sterin-Borda; Sandra Bacman; Enri Borda
Journal:  Clin Immunol       Date:  2002-07       Impact factor: 3.969

10.  Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjögren's syndrome.

Authors:  P Tengnér; A K Halse; H J Haga; R Jonsson; M Wahren-Herlenius
Journal:  Arthritis Rheum       Date:  1998-12
View more
  19 in total

Review 1.  Experience with experimental biological treatment and local gene therapy in Sjogren's syndrome: implications for exocrine pathogenesis and treatment.

Authors:  B M Lodde; B J Baum; P P Tak; G Illei
Journal:  Ann Rheum Dis       Date:  2006-07-31       Impact factor: 19.103

2.  Novel animal models for Sjögren's syndrome: expression and transfer of salivary gland dysfunction from regulatory T cell-deficient mice.

Authors:  S-T Ju; W N Jarjour; R Sharma; L Zheng; X Guo; S M Fu
Journal:  J Autoimmun       Date:  2007-01-03       Impact factor: 7.094

Review 3.  What can Sjögren's syndrome-like disease in mice contribute to human Sjögren's syndrome?

Authors:  Ammon B Peck; Cuong Q Nguyen
Journal:  Clin Immunol       Date:  2017-05-03       Impact factor: 3.969

Review 4.  The coexistence of Sjögren's syndrome and primary biliary cirrhosis: a comprehensive review.

Authors:  Ying Sun; Weici Zhang; Baosen Li; Zhengsheng Zou; Carlo Selmi; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

5.  Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome.

Authors:  B M Lodde; F Mineshiba; J Wang; A P Cotrim; S Afione; P P Tak; B J Baum
Journal:  Ann Rheum Dis       Date:  2005-06-23       Impact factor: 19.103

6.  Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway.

Authors:  Alexander Espinosa; Valerie Dardalhon; Susanna Brauner; Aurelie Ambrosi; Rowan Higgs; Fransisco J Quintana; Maria Sjöstrand; Maija-Leena Eloranta; Joan Ní Gabhann; Ola Winqvist; Birgitta Sundelin; Caroline A Jefferies; Björn Rozell; Vijay K Kuchroo; Marie Wahren-Herlenius
Journal:  J Exp Med       Date:  2009-07-27       Impact factor: 14.307

7.  Animals Models of Human T Cell Leukemia Virus Type I Leukemogenesis.

Authors:  Stefan Niewiesk
Journal:  ILAR J       Date:  2016

Review 8.  Immunobiology of T Cells in Sjögren's Syndrome.

Authors:  Yuan Yao; Jin-Fen Ma; Christopher Chang; Ting Xu; Cai-Yue Gao; M Eric Gershwin; Zhe-Xiong Lian
Journal:  Clin Rev Allergy Immunol       Date:  2021-02       Impact factor: 8.667

9.  Correspondence between clinical improvement and proteomic changes of the salivary peptide complex in a child with primary Sjögren syndrome.

Authors:  Donato Rigante; Rosanna Inzitari; Maurizio Carone; Chiara Fanali; Achille Stabile; Tiziana Cabras; Ettore Capoluongo; Stefania Gaspari; Giuseppe Barone; Massimo Castagnola
Journal:  Rheumatol Int       Date:  2008-01-12       Impact factor: 2.631

Review 10.  Follicular Helper T (Tfh) Cells in Autoimmune Diseases and Allograft Rejection.

Authors:  Yun-Hui Jeon; Youn Soo Choi
Journal:  Immune Netw       Date:  2016-08-23       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.